Home » Topics » BioWorld

BioWorld
RSS

ISIS IPO REFLECTS TOUGHER MARKET

May 20, 1991

ARGUS BEGINS PHASE I TRIALS OF ANTI-AIDS DRUG

May 17, 1991

CALGENE COMES CLEAN WITH GENE

May 17, 1991

GENETICALLY TREATED PLANTS RESIST FUNGUS

May 17, 1991

TEVA TO FILE FOR PUBLIC OFFERING OF ADRs

May 17, 1991

PARTICLE GUN TRANSFORMS COTTON

May 17, 1991

T CELL COMPLETES PRIVATE PLACEMENT

May 17, 1991

NEWS BRIEFS

May 16, 1991

REGENERON FALLS TO HALF OF IPO PRICE

May 16, 1991

IBA SAYS FDA USER FEES MAY BE OK

May 16, 1991

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...